Compare Cart
  • Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Cover Image
Market Research Report
Product code 
1058446

Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
Published: | IMARC Services Private Limited | 107 Pages | Delivery time: 2-3 business days

Price

Back to Top
Travel Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
Published: February 12, 2022
IMARC Services Private Limited
Content info: 107 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

The global travel vaccines market reached a value of US$ 3.2 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.6 Billion by 2027, exhibiting a CAGR of 11.1% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Travel vaccines, also known as travel immunizations, are vaccines travelers can get before they visit certain regions across the globe which help protect them from serious diseases. Travel vaccines work by exposing the body to a microorganism or parts of the microorganism of the disease it will protect against. The body responds to the vaccination by making antibodies that will protect it against a situation where there is an exposure to the disease in the future. The number of international tourist arrivals worldwide increased from 1.0 Billion in 2012 to nearly 1.4 Billion in 2018. A significant number of these travelers journey from developed countries to regions with endemic diseases. As more people travel to countries with endemic diseases, the demand for vaccines will continue to increase. Moreover, regulatory authorities across the globe have also mandated that travelers should be vaccinated before traveling to disease-prone regions. As a result, travel vaccines have now become an essential requirement in an international travelers list. For instance, the Ministry of Health in the Kingdom of Saudi Arabia requires that all travelers arriving for Hajj and Umrah from countries or areas at risk of diseases such as yellow fever, Meningococcal meningitis and Poliomyelitis must present a valid vaccination certificate. Other factors driving the demand for travel vaccines include increasing awareness levels, technological advancements and increasing incidence of life-threatening infectious diseases.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global travel vaccines market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on composition and disease.
  • Breakup by Composition: Mono Vaccines
  • Combination Vaccines
  • Combination vaccines currently account for the majority of the market share as they are given to travelers in order to protect against multiple diseases.

Breakup by Disease:

  • Hepatitis A
  • DPT
  • Yellow Fever
  • Typhoid
  • Hepatitis B
  • Measles and Mumps
  • Rabies
  • Meningococcal
  • Varicella
  • Japanese Encephalitis
  • Others
  • Amongst these, hepatitis A represents the largest disease, dominating the market. It is a viral disease that can be transmitted through direct contact with an infectious person or the consumption of contaminated food and water.
  • Regional Insights: Asia Pacific
  • North America
  • Europe
  • Middle East and Africa
  • Latin America
  • On the geographical front, North America enjoys the leading position in the market. A large number of companies in the region are introducing a superior range of travel vaccines, including a vaccine against varicella.

Competitive Landscape:

The market is concentrated in nature with the presence of a handful of manufacturers who compete in terms of prices and quality. Some of the leading players operating in the market are:

  • GlaxoSmithKline Pharmaceuticals Limited
  • Sanofi Pasteur
  • Merck & Co., Inc.
  • Novartis AG
  • Pfizer Inc.
  • ALK-Abello A/S
  • Bavarian Nordic A/S
  • Crucell (Subsidiary of Johnson & Johnson)
  • CSL Limited
  • AstraZeneca PLC
  • Altimmune, Inc.
  • Abbott Laboratories
  • Hoffmann-La Roche, Inc. Key Questions Answered in this Report
  • 1. What was the global travel vaccines market size in 2021?
  • 2. What will be the travel vaccines market outlook during the forecast period (2022-2027)?
  • 3. What are the global travel vaccines market drivers?
  • 4. What are the major trends in the global travel vaccines market?
  • 5. What is the impact of COVID-19 on the global travel vaccines market?
  • 6. What is the global travel vaccines market breakup by composition?
  • 7. What is the global travel vaccines market breakup by disease?
  • 8. What are the major regions in the global travel vaccines market?
  • 9. Who are the leading travel vaccines market players?
Product Code: SR0222A297_Report

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Travel Vaccines Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Composition
  • 5.5 Market Breakup by Disease
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast

6 Market Breakup by Composition

  • 6.1 Mono Vaccines
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Combination Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Disease

  • 7.1 Hepatitis A
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 DPT
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Yellow Fever
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Typhoid
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Hepatitis B
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Measles and Mumps
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Rabies
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Meningococcal
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast
  • 7.9 Varicella
    • 7.9.1 Market Trends
    • 7.9.2 Market Forecast
  • 7.10 Japanese Encephalitis
    • 7.10.1 Market Trends
    • 7.10.2 Market Forecast
  • 7.11 Others
    • 7.11.1 Market Trends
    • 7.12.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Global Travel Vaccines Industry: SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Global Travel Vaccines Industry: Value Chain Analysis

  • 10.1 Exploratory Stage
  • 10.2 Preclinical and Clinical Development
  • 10.3 Regulatory Approval
  • 10.4 Manufacturing
  • 10.5 Marketing and Distribution

11 Global Travel Vaccines Industry: Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Global Travel Vaccines Industry: Price Analysis

13 Travel Vaccines Manufacturing Process

  • 13.1 Product Overview
  • 13.2 Raw Material Requirements
  • 13.3 Manufacturing Process
  • 13.4 Key Success and Risk Factors

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 GlaxoSmithKline Pharmaceuticals Limited
    • 14.3.2 Sanofi Pasteur
    • 14.3.3 Merck & Co., Inc.
    • 14.3.4 Novartis AG
    • 14.3.5 Pfizer Inc.
    • 14.3.6 ALK-Abello A/S
    • 14.3.7 Bavarian Nordic A/S
    • 14.3.8 Crucell (Subsidiary of Johnson & Johnson)
    • 14.3.9 CSL Limited
    • 14.3.10 AstraZeneca PLC
    • 14.3.11 Altimmune, Inc.
    • 14.3.12 Abbott Laboratories
    • 14.3.13 Hoffmann-La Roche, Inc.

List of Figures

  • Figure 1: Global: Travel Vaccines Market: Major Drivers and Challenges
  • Figure 2: Global: Travel Vaccines Market: Sales Value (in Billion US$), 2016-2021
  • Figure 3: Global: Travel Vaccines Market: Breakup by Composition (in %), 2021
  • Figure 4: Global: Travel Vaccines Market: Breakup by Disease (in %), 2021
  • Figure 5: Global: Travel Vaccines Market: Breakup by Region (in %), 2021
  • Figure 6: Global: Travel Vaccines Market Forecast: Sales Value (in Billion US$), 2022-2027
  • Figure 7: Global: Travel Vaccines Industry: SWOT Analysis
  • Figure 8: Global: Travel Vaccines Industry: Value Chain Analysis
  • Figure 9: Global: Travel Vaccines Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Travel Vaccines (Mono Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 11: Global: Travel Vaccines (Mono Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 12: Global: Travel Vaccines (Combination Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 13: Global: Travel Vaccines (Combination Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 14: Global: Travel Vaccines (Hepatitis A) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 15: Global: Travel Vaccines (Hepatitis A) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 16: Global: Travel Vaccines (DPT) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 17: Global: Travel Vaccines (DPT) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 18: Global: Travel Vaccines (Yellow Fever) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 19: Global: Travel Vaccines (Yellow Fever) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 20: Global: Travel Vaccines (Typhoid) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 21: Global: Travel Vaccines (Typhoid) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 22: Global: Travel Vaccines (Hepatitis B) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 23: Global: Travel Vaccines (Hepatitis B) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 24: Global: Travel Vaccines (Measles and Mumps) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 25: Global: Travel Vaccines (Measles and Mumps) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 26: Global: Travel Vaccines (Rabies) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 27: Global: Travel Vaccines (Rabies) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 28: Global: Travel Vaccines (Meningococcal) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 29: Global: Travel Vaccines (Meningococcal) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 30: Global: Travel Vaccines (Varicella) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 31: Global: Travel Vaccines (Varicella) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 32: Global: Travel Vaccines (Japanese Encephalitis) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 33: Global: Travel Vaccines (Japanese Encephalitis) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 34: Global: Travel Vaccines (Others) Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 35: Global: Travel Vaccines (Others) Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 36: North America: Travel Vaccines Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 37: North America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 38: Europe: Travel Vaccines Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 39: Europe: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 40: Asia Pacific: Travel Vaccines Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 41: Asia Pacific: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 42: Middle East and Africa: Travel Vaccines Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 43: Middle East and Africa: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 44: Latin America: Travel Vaccines Market: Sales Value (in Million US$), 2016 & 2021
  • Figure 45: Latin America: Travel Vaccines Market Forecast: Sales Value (in Million US$), 2022-2027
  • Figure 46: Travel Vaccines Manufacturing: Process Flow

 

List of Tables

  • Table 1: Global: Travel Vaccines Market: Key Industry Highlights, 2021 and 2027
  • Table 2: Global: Travel Vaccines Market Forecast: Breakup by Composition (in Million US$), 2022-2027
  • Table 3: Global: Travel Vaccines Market Forecast: Breakup by Disease (in Million US$), 2022-2027
  • Table 4: Global: Travel Vaccines Market Forecast: Breakup by Region (in Million US$), 2022-2027
  • Table 5: Travel Vaccines: Raw Material Requirements
  • Table 6: Global: Travel Vaccines Market Structure
  • Table 7: Global: Travel Vaccines Market: Key Players